Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Neoplasm
100%
Breast Cancer
86%
Breast Carcinoma
68%
Recurrent Disease
50%
Surgical Margin
45%
Neoadjuvant Chemotherapy
45%
Oncotype DX
45%
Epidermal Growth Factor Receptor 2
35%
Gamma Urogastrone
35%
Abdominal Cancer
34%
Cancer Staging
27%
Cylindroma
26%
Immunohistochemistry
24%
Triple Negative Breast Cancer
22%
Programmed Death 1 Ligand 1
22%
Endometrium Carcinoma
22%
Skin Tumor
22%
Tumour Heterogeneity
22%
Adenocarcinoma
22%
Magnetic Resonance Imaging
22%
Breast Cancer Survival
22%
Nucleosome
22%
Next Generation Sequencing
22%
Mohs Surgery
22%
Quadrantectomy
22%
Lymphadenopathy
22%
Histopathology
22%
Recurrence Risk
22%
Small-Cell Carcinoma
22%
Neurinoma
22%
Confocal Laser Scanning Microscopy
22%
Gene Expression Profiling
22%
Cytotoxic T-Cell
22%
Cancer Survival
22%
Disease Free Survival
22%
Helicase
13%
Histone Deacetylase 2
13%
Cancer Tissue
13%
DNA Binding Protein
13%
Pathologist
11%
Basal-Cell Carcinoma
11%
Malignant Neoplasm
11%
Survival Analysis
11%
Immunocompetent Cell
10%
Multivariate Analysis
9%
Biopsy Technique
9%
Lymph Node Metastasis
9%
Hormone Receptor
9%
Cancer
8%
Lymph Node
7%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
47%
Gene Expression
30%
Estrogen Receptor
27%
Diagnostic Biomarker
22%
Immunocompetent Cell
22%
Peptide Nucleic Acid
22%
DNA-binding Protein
22%
Helicase
22%
Upregulation
22%
Dispersity
22%
Gene Expression Profiling
22%
Transcriptome
22%
Histone Deacetylase 2
22%
Next Generation Sequencing
22%
Interferon
22%
Chromodomain
22%
Protein Expression
22%
Nucleosome
22%
Genome-Wide Analysis of Gene Expression
22%
Immune Response
22%
Drug Screening
22%
CD8
22%
Erlotinib
22%
Cancer Survival
22%
Anticancer
22%
T Cell
22%
Survival Rate
22%
Zonulin
22%
Lysozyme
11%
Genetics
11%
Transcriptomics
11%
Bioinformatics
11%
Cellular Immunity
11%
Multivariate Analysis
11%
Leukocyte
11%
Gene Ontology
11%
Immunoglobulin Superfamily
11%
Lymphocyte
11%
Adaptive Immunity
11%
Cytometry
11%
Cancer Cell
11%
Protein Tyrosine Phosphatase
11%
PD-L1
11%
Tumor-Infiltrating Lymphocytes
11%
Cell Motility
11%
Cell Migration
11%
Cell Invasion
11%
Messenger RNA
11%
Disease Free Survival
9%
Artificial Intelligence
7%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
81%
Triple Negative Breast Cancer
45%
Breast Carcinoma
45%
Gamma Urogastrone
28%
Epidermal Growth Factor Receptor 2
28%
Recurrent Disease
27%
Chemotherapy
24%
Programmed Death 1 Ligand 1
22%
Peptide Nucleic Acid
22%
Brain Protein
22%
Transcriptome
22%
Endometrium Carcinoma
22%
Asthma
22%
Mouse Model
22%
Malignant Neoplasm
17%
Cancer of Unknown Primary Site
15%
DNA Binding Protein
13%
Histone Deacetylase 2
13%
Helicase
13%
Abdominal Cancer
11%
Estrogen Receptor
7%
RNA-Sequencing
7%
Breast Cancer
7%
Fatality
7%
Event Free Survival
5%
Biological Marker
5%